At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 41 enrolled
Drug / intervention
Fentanyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl
University of Texas Southwestern Medical Center·interventional·Posted Oct 23, 2019·Updated Jan 24, 2022
In Brief
A Phase 2 clinical trial evaluating Fentanyl and Placebo for Healthy. Completed, enrolled 41 participants across 1 site.
Detailed Summary
The purpose of this project is to test how fentanyl, an analgesic currently employed in the pre-hospital setting by the US Army, alters the capacity to tolerate a hemorrhagic insult in humans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
Enrollment StartJun 2019
First PostedOct 2019
Primary CompletionNov 2020
TodayJul 2026
First PostedOct 23, 2019
Enrollment StartJun 1, 2019
Primary CompletionNov 18, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 6.7 years ago
Interventions
Fentanyldrug
Subjects will receive 75 ug Fentanyl while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.
Placeboother
Subjects will receive saline while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.